Source evidence
Something wrong or missing? Send an update. Fixed within 24 hours.
OncoDNA Series A
Participating investor Ackermans & van Haaren announces EUR 7.7m equity; later company history rounds this to EUR 8m.
Participating investor Ackermans & van Haaren announces EUR 7.7m equity; later company history rounds this to EUR 8m.
Something wrong or missing? Send an update. Fixed within 24 hours.